Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining Neuroplasticity Modulation as Mechanistic Basis of tDCS Treatment Effects on Auditory Verbal Hallucination in Schizophrenia

NCT04629352 is registered in ClinicalTrials.gov with National Institute of Mental Health and Neuro Sciences, India as lead sponsor.

NCT NCT04629352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04629352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining Neuroplasticity Modulation as Mechanistic Basis of tDCS Treatment Effects on Auditory Verbal Hallucination in Schizophrenia
Lead sponsor
National Institute of Mental Health and Neuro Sciences, India
Phase
Not applicable
Overall status
Recruiting
Start date
April 2, 2024
Completion date
August 31, 2026
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia